Rectify Pharma appoints Bharat Reddy as CBO
Cambridge, USA-based biotech Rectify Pharmaceuticals today announced the appointment of Bharat Reddy as chief business officer (CBO).
Rectify noted that Mr Reddy brings over 10 years of business development and strategy expertise in the biopharmaceutical industry and will lead business development activities for the company.
“I am delighted to welcome Bharat to the Rectify team,” said Rajesh Devraj, president and chief executive of Rectify. “His proven track record of advancing partnerships in the biopharma industry will be critical as we build the industry-leading ABC transporter therapeutics company and advance our business goals,” he explained.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
More on this story...
Today's issue
Company Spotlight
More Features in Biotechnology
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze